🔎 Trials Near Me

Akèy › Kansè nan tete › Texas › Sugar Land

Etid klinik pou Kansè nan tete nan Sugar Land, TX

7 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Sugar Land (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Ap rekriteFaz 3
  • UT MD Anderson - Sugar Land, Sugar Land
  • Houston Methodist Sugar Land Hospital, Sugar Land
Laj 18 a 60 · Fanm · Mizajou Sep 2, 2026 · NCT05879926

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Ap rekriteFaz 3
  • Texas Oncology - Gulf Coast, Sugar Land
Laj 18 a 100 · Tout sèks · Mizajou Aug 6, 2026 · NCT05232916

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1
  • The University of Texas, MD Anderson Cancer Center - Sugar Land, Sugar Land
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07318805

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Ap rekriteFaz 3
  • MD Anderson in Sugar Land, Sugar Land
  • Houston Methodist Sugar Land Hospital, Sugar Land
Laj 50 a 70 · Tout sèks · Mizajou Apr 23, 2026 · NCT04852887

Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

Ap rekriteEtid obsèvasyon
  • MD Anderson in Sugar Land, Sugar Land
Laj 18 ak plis · Tout sèks · Mizajou Apr 15, 2026 · NCT00477100

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Ap rekriteEtid obsèvasyon
  • Texas Oncology - Sugar Land, Sugar Land
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2025 · NCT03053193

Etid Kansè nan tete nan lòt vil

Lòt etid nan Sugar Land

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.